company background image
BAVA logo

Bavarian Nordic CPSE:BAVA Stock Report

Last Price

kr.150.10

Market Cap

kr.11.7b

7D

-2.2%

1Y

-20.3%

Updated

22 Apr, 2024

Data

Company Financials +

Bavarian Nordic A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bavarian Nordic
Historical stock prices
Current Share Pricekr.150.10
52 Week Highkr.222.00
52 Week Lowkr.125.55
Beta1.33
1 Month Change-4.27%
3 Month Change-5.95%
1 Year Change-20.33%
3 Year Change-45.93%
5 Year Change7.29%
Change since IPO-41.14%

Recent News & Updates

Improved Revenues Required Before Bavarian Nordic A/S (CPH:BAVA) Shares Find Their Feet

Apr 09
Improved Revenues Required Before Bavarian Nordic A/S (CPH:BAVA) Shares Find Their Feet

Does Bavarian Nordic (CPH:BAVA) Have A Healthy Balance Sheet?

Feb 26
Does Bavarian Nordic (CPH:BAVA) Have A Healthy Balance Sheet?

Recent updates

Improved Revenues Required Before Bavarian Nordic A/S (CPH:BAVA) Shares Find Their Feet

Apr 09
Improved Revenues Required Before Bavarian Nordic A/S (CPH:BAVA) Shares Find Their Feet

Does Bavarian Nordic (CPH:BAVA) Have A Healthy Balance Sheet?

Feb 26
Does Bavarian Nordic (CPH:BAVA) Have A Healthy Balance Sheet?

Bavarian Nordic A/S' (CPH:BAVA) Business And Shares Still Trailing The Industry

Jan 03
Bavarian Nordic A/S' (CPH:BAVA) Business And Shares Still Trailing The Industry

Bavarian Nordic A/S (CPH:BAVA) Shares Could Be 45% Below Their Intrinsic Value Estimate

Dec 10
Bavarian Nordic A/S (CPH:BAVA) Shares Could Be 45% Below Their Intrinsic Value Estimate

Here's Why Bavarian Nordic (CPH:BAVA) Can Manage Its Debt Responsibly

Nov 15
Here's Why Bavarian Nordic (CPH:BAVA) Can Manage Its Debt Responsibly

Does Bavarian Nordic (CPH:BAVA) Have A Healthy Balance Sheet?

Aug 17
Does Bavarian Nordic (CPH:BAVA) Have A Healthy Balance Sheet?

Improved Revenues Required Before Bavarian Nordic A/S (CPH:BAVA) Shares Find Their Feet

Apr 19
Improved Revenues Required Before Bavarian Nordic A/S (CPH:BAVA) Shares Find Their Feet

Is Bavarian Nordic (CPH:BAVA) Weighed On By Its Debt Load?

Jan 03
Is Bavarian Nordic (CPH:BAVA) Weighed On By Its Debt Load?

Bavarian Nordic (CPH:BAVA) Has Debt But No Earnings; Should You Worry?

Sep 15
Bavarian Nordic (CPH:BAVA) Has Debt But No Earnings; Should You Worry?

Rainbows and Unicorns: Bavarian Nordic A/S (CPH:BAVA) Analysts Just Became A Lot More Optimistic

Jul 24
Rainbows and Unicorns: Bavarian Nordic A/S (CPH:BAVA) Analysts Just Became A Lot More Optimistic

Industry Analysts Just Made A Notable Upgrade To Their Bavarian Nordic A/S (CPH:BAVA) Revenue Forecasts

Jun 14
Industry Analysts Just Made A Notable Upgrade To Their Bavarian Nordic A/S (CPH:BAVA) Revenue Forecasts

Analyst Forecasts Just Became More Bearish On Bavarian Nordic A/S (CPH:BAVA)

May 31
Analyst Forecasts Just Became More Bearish On Bavarian Nordic A/S (CPH:BAVA)

Is Bavarian Nordic (CPH:BAVA) Using Debt In A Risky Way?

May 06
Is Bavarian Nordic (CPH:BAVA) Using Debt In A Risky Way?

Bavarian Nordic A/S (CPH:BAVA) Analysts Just Cut Their EPS Forecasts Substantially

Mar 13
Bavarian Nordic A/S (CPH:BAVA) Analysts Just Cut Their EPS Forecasts Substantially

Health Check: How Prudently Does Bavarian Nordic (CPH:BAVA) Use Debt?

Oct 21
Health Check: How Prudently Does Bavarian Nordic (CPH:BAVA) Use Debt?

Calculating The Fair Value Of Bavarian Nordic A/S (CPH:BAVA)

Sep 16
Calculating The Fair Value Of Bavarian Nordic A/S (CPH:BAVA)

Shareholder Returns

BAVADK BiotechsDK Market
7D-2.2%-2.5%-1.4%
1Y-20.3%-15.7%21.5%

Return vs Industry: BAVA underperformed the Danish Biotechs industry which returned -15.7% over the past year.

Return vs Market: BAVA underperformed the Danish Market which returned 21.5% over the past year.

Price Volatility

Is BAVA's price volatile compared to industry and market?
BAVA volatility
BAVA Average Weekly Movement5.4%
Biotechs Industry Average Movement7.5%
Market Average Movement4.6%
10% most volatile stocks in DK Market9.1%
10% least volatile stocks in DK Market3.0%

Stable Share Price: BAVA has not had significant price volatility in the past 3 months.

Volatility Over Time: BAVA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19921,379Paul Chaplinwww.bavarian-nordic.com

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase III clinical trial for the treatment of SARS-CoV-2.

Bavarian Nordic A/S Fundamentals Summary

How do Bavarian Nordic's earnings and revenue compare to its market cap?
BAVA fundamental statistics
Market capkr.11.70b
Earnings (TTM)kr.1.48b
Revenue (TTM)kr.7.06b

7.9x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAVA income statement (TTM)
Revenuekr.7.06b
Cost of Revenuekr.1.90b
Gross Profitkr.5.16b
Other Expenseskr.3.69b
Earningskr.1.48b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 08, 2024

Earnings per share (EPS)18.93
Gross Margin73.07%
Net Profit Margin20.89%
Debt/Equity Ratio0.2%

How did BAVA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.